Standardization of spirometry 2019 update. An official American thoracic society and European respiratory society technical statement

BL Graham, I Steenbruggen, MR Miller… - American journal of …, 2019 - atsjournals.org
Background: Spirometry is the most common pulmonary function test. It is widely used in the
assessment of lung function to provide objective information used in the diagnosis of lung …

Asthma: pathogenesis and novel drugs for treatment

JT Olin, ME Wechsler - Bmj, 2014 - bmj.com
Asthma affects almost 20 million people in the United States and more than 300 million
people worldwide. Of these, 10-15% have severe asthma, which is refractory to commonly …

The Saudi Initiative for Asthma-2021 Update: Guidelines for the diagnosis and management of asthma in adults and children

MS Al-Moamary, SA Alhaider, AA Alangari… - Annals of thoracic …, 2021 - journals.lww.com
Abstract The Saudi Initiative for Asthma 2021 (SINA-2021) is the fifth version of asthma
guidelines for the diagnosis and management of asthma for adults and children, which is …

Pulmonary drug metabolism, clearance, and absorption

B Olsson, E Bondesson, L Borgström… - … pulmonary drug delivery, 2011 - Springer
Delivering therapeutic agents to the lungs requires a deep understanding of the kinetics and
dynamics of drugs in this biologically and physiologically complex system. In this chapter …

The Saudi Initiative for Asthma-2019 Update: Guidelines for the diagnosis and management of asthma in adults and children

MS Al-Moamary, SA Alhaider, AA Alangari… - Annals of thoracic …, 2019 - journals.lww.com
This is the fourth version of the updated guidelines for the diagnosis and management of
asthma, developed by the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi …

The Saudi Initiative for Asthma-2016 update: Guidelines for the diagnosis and management of asthma in adults and children

MS Al-Moamary, SA Alhaider, MM Idrees… - Annals of Thoracic …, 2016 - journals.lww.com
This is an updated guideline for the diagnosis and management of asthma, developed by
the Saudi Initiative for Asthma (SINA) group, a subsidiary of the Saudi Thoracic Society. The …

Therapeutics on the clock: Circadian medicine in the treatment of chronic inflammatory diseases

H Jacob, AM Curtis, CJ Kearney - Biochemical Pharmacology, 2020 - Elsevier
The circadian clock is a collection of endogenous oscillators with a periodicity of~ 24 h.
Recently, our understanding of circadian rhythms and their regulation at genomic and …

Pharmacotherapy for the treatment of asthma: current treatment options and future directions

GW Choby, S Lee - International Forum of Allergy & Rhinology, 2015 - Wiley Online Library
Background Asthma is a prevalent disease characterized by chronic inflammatory changes
of the airway and marked by airway hyperresponsiveness, edema, and excess mucus …

[HTML][HTML] Ultra-LABAs for the treatment of asthma

M Cazzola, P Rogliani, MG Matera - Respiratory Medicine, 2019 - Elsevier
The term ultra-LABA indicates once-daily β2-AR agonists (abediterol, indacaterol, olodaterol
and vilanterol) that are single enantiomers of the (R)-configuration. All have a near full …

Novel bronchodilators in asthma

M Cazzola, A Segreti, MG Matera - Current opinion in pulmonary …, 2010 - journals.lww.com
Bronchodilators are central in the symptomatic management of asthma. It is likely that the
once-daily dosing of a bronchodilator would be a significant convenience and probably a …